Peters Sheila Annie, Ungell Anna-Lena, Dolgos Hugues
Discovery DMPK, Astrazeneca R&D, Mölndal, Sweden.
Curr Opin Drug Discov Devel. 2009 Jul;12(4):509-18.
Physiologically based pharmacokinetics (PBPK) models are increasingly being used in the lead optimization (LO) process. Although there are currently few literature reports of the application of PBPK, the scope of PBPK modeling is expanding and there is a steady increase in the number of publications in this field. Recent publications covering four important areas of the application of PBPK modeling in LO have been reviewed.
基于生理的药代动力学(PBPK)模型在先导化合物优化(LO)过程中的应用越来越广泛。尽管目前关于PBPK应用的文献报道较少,但PBPK建模的范围正在扩大,该领域的出版物数量也在稳步增加。本文综述了近期涵盖PBPK建模在LO中应用的四个重要领域的出版物。